IMRN on Nasdaq

Immuron Ltd

Immuron Ltd is a pharmaceutical preparations company, listed on Nasdaq (IMRN).1

Price unavailable

Last updated Oct 20, 2026.

Overview

Compare with another stock.

  • TickerIMRN on Nasdaq1
  • IndustryPharmaceutical Preparations1
  • HeadquartersC31
  • Incorporated inAustralia2
  • Business address62 Lygon Street, Level 3, Carlton, Victoria, C3 30532
  • Filer categoryNon-accelerated filer2

Australia, Canada, and in new markets. We previously advised that the development of CampETEC product was discontinued.3 From its latest annual report

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Financial statements

Every line of the income statement as filed: the last 3 fiscal years, latest first.4

Period ending2026-06-302025-06-302024-06-30
Revenue from contracts with customers7.7M AUD7.3M AUD4.9M AUD
Cost of Goods Sold-2.7M AUD-2.5M AUD-1.6M AUD
Gross Profit5.0M AUD4.8M AUD3.3M AUD
Grant Income1.2M AUD1.4M AUD3.4M AUD
Fair value losses to financial assets-557.7K AUD
Net foreign exchange gains/(losses)-285.1K AUD12.2K AUD-27.6K AUD
General and administrative expenses-4.3M AUD-4.5M AUD-4.6M AUD
Research and development expenses-1.9M AUD-3.6M AUD-5.4M AUD
Selling and marketing expenses-3.5M AUD-3.5M AUD-2.0M AUD
Operating loss-3.9M AUD-5.3M AUD-5.8M AUD
Finance income185.4K AUD135.9K AUD327.8K AUD
Finance expenses-14.7K AUD-7.3K AUD-7.6K AUD
Finance costs - net170.7K AUD128.6K AUD320.2K AUD
Share of loss from associates-1.5M AUD
Loss Before Income Tax-3.7M AUD-5.2M AUD-6.9M AUD
Loss for the Period-3.7M AUD-5.2M AUD-6.9M AUD
Exchange differences on translation of foreign operations16.3K AUD-1.4K AUD2.3K AUD
Total Comprehensive Loss for the Period-3.7M AUD-5.2M AUD-6.9M AUD
Basic Loss per Share (in cents per share) (in Dollars per share)-1.24 AUD-2.26 AUD-3.04 AUD
Diluted Loss per Share (in cents per share) (in Dollars per share)-1.24 AUD-2.26 AUD-3.04 AUD

Compare Immuron Ltd with another company

What it owns

What Immuron Ltd reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Investments

ItemLatestA year beforeChange
Cash and cash equivalents$2.7M5 Jun 30, 2024$4.8M5 Jun 30, 2023−43.0%

Leadership

Who has led Immuron Ltd, and when. Pick a name to see everywhere that person has worked.

Board members and other officers (5)

Timeline

  1. Apr 29, 2026New chief executive Steven George Lydeamore becomes CEO6

Filings

204 filings to the SEC since October 2021: 6 annual reports, 8 insider forms, 190 other. The latest 20:

  1. Oct 13, 20266-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
  2. Sep 24, 202620-F ANNUAL REPORT EDGAR
  3. Sep 24, 20266-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
  4. Sep 22, 20266-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
  5. Sep 4, 20266-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
  6. Aug 28, 20266-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
  7. Aug 19, 20266-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
  8. Aug 13, 20266-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
  9. Jul 27, 20266-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
  10. Jul 21, 20266-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
  11. Jul 20, 20266-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
  12. Jul 16, 20266-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
  13. Jul 6, 20266-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
  14. Jun 29, 20266-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
  15. Jun 23, 20266-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
  16. Jun 22, 20266-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
  17. May 28, 20266-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
  18. May 14, 20263 EDGAR
  19. May 14, 20263 EDGAR
  20. May 8, 20266-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR

The 204 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Held by these funds

The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026. Change is in shares since the quarter before.

FundSharesValueShare of the fundChange
Citadel Advisors LLC43,123$45.7K0.0%+29,319
Rhumbline Advisers7,367$7.8K0.0%No change
Bnp Paribas Financial Markets5,200$5.5K0.0%+600
Morgan Stanley1,700$1.8K0.0%−28,874
UBS Group AG363$3850.0%New
Hrt Financial LP20,584$210.0%New

13F reports cover disclosed long positions in U.S. stocks only.

SEC filer profile

How Immuron Ltd is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARImmuron Ltd1
  • CIK0001660046
  • Filer statusNon-accelerated filer not an emerging growth company; not a shell company3
  • Incorporated inAustralia3
  • Fiscal year endsJune 301
  • Industry code (SIC)2834 Pharmaceutical Preparations1
  • SEC reviewing officeOffice of Life Sciences, Division of Corporation Finance1
  • Business address62 Lygon Street, Level 3, Carlton, Victoria, C3 30531
  • Phone61 03 9824 52541
  • Shares outstanding322,848,081 shares as of Jun 30, 20263
  • AuditorGRANT THORNTON AUDIT PTY LTD, Melbourne, Victoria PCAOB ID 2233; no auditor attestation of internal control over financial reporting3
  • On EDGAR sinceDec 21, 20161
  • Filings421 in all: 6-K (322), CORRESP (20), 20-F (10), UPLOAD (10), 3 (8), F-1/A (8), 424B5 (6), FWP (5)1
    All 25 form types

    424B3 (4), EFFECT (4), 6-K/A (3), F-3 (3), SC 13G (3), SC 13G/A (3), 424B4 (2), 25-NSE (1), 8-A12B (1), CERTNAS (1), CT ORDER (1), F-1 (1), F-1MEF (1), NT 20-F (1), POS AM (1), RW (1), SC 13D (1)

  • Latest filingsAnnual report (20-F) Sep 24, 2026

Securities registered for trading

ClassSymbolExchange
American Depositary Shares, each representing 40 Ordinary SharesIMRNThe Nasdaq Stock Market LLC

From the cover page of the 20-F filed Sep 24, 2026 (Section 12(b) of the Exchange Act).3